| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8668402 | Journal of Clinical Lipidology | 2018 | 10 Pages |
Abstract
An intermediate dose of OM3-CA (2Â g daily) significantly lowers TG and non-high-density lipoprotein cholesterol concentrations in patients with SHTG and may benefit individuals at risk of acute pancreatitis and cardiovascular disease.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Erik S.G. MD, PhD, Andrey V. MD, PhD, Tjerk W.A. MD, PhD, Mats PhD, Hong MSc, Michael H. MD,